Can Diabetics Take Prednisone Safely?

Diabetics can take prednisone when the medical situation calls for it, but doing so safely requires active glucose management and close communication with a prescriber. Prednisone reliably drives blood sugar higher through a two-pronged attack on insulin function, and for people who already have diabetes, the spike can be dramatic enough to land someone in the hospital. The drug is not off-limits, but treating it as routine is where the danger lies.

How Prednisone Disrupts Blood Sugar

Prednisone belongs to the glucocorticoid family, and the “gluco” in the name is a hint about what these drugs do. Even at low doses, prednisone makes the liver pump out more glucose while simultaneously making muscle and fat tissue less responsive to insulin. Research on patients taking low-dose prednisolone for inflammatory conditions found that a single course reduced the body’s ability to suppress liver glucose output and cut peripheral glucose uptake at the same time.¹ That alone would be enough to raise blood sugar. But there is a second hit: glucocorticoids directly impair the insulin-producing beta cells in the pancreas, reducing how much insulin they release when glucose rises.²

For people with type 2 diabetes, this second hit may matter more than the first. A study comparing prednisone’s short-term effects in people with type 2 diabetes versus healthy controls found that in the diabetes group, the dominant driver of worsening blood sugar was decreased beta-cell insulin secretion rather than increased insulin resistance.³ This matters practically because it means the pancreas is already under strain in type 2 diabetes, and prednisone pushes it further. Adjusting insulin resistance alone, say by increasing metformin, may not be enough to compensate.

The Afternoon and Evening Spike

One of the trickiest things about prednisone-related blood sugar changes is the timing. When taken as a morning dose, prednisone’s glucose-raising effect peaks in the afternoon and evening. Fasting morning blood sugar might look acceptable, lulling both patients and clinicians into thinking the situation is under control, while readings after lunch and dinner soar. Continuous glucose monitoring data on patients with steroid-induced hyperglycemia showed that affected individuals spent close to six hours per day above the target glucose range, with over an hour of that in severely elevated territory.⁴ Glucose variability was also roughly double what it was in patients without steroid-induced hyperglycemia. That kind of swing is hard to catch with a single morning fingerstick.

If you are already checking your blood sugar regularly, the practical takeaway is to add checks before dinner and at bedtime while you are on prednisone. If you wear a continuous glucose monitor, it becomes especially useful during a steroid course because it captures the afternoon drift that point-in-time checks miss. The same monitoring study noted that a metric called the glucose management indicator, which reflects the previous two weeks of glucose behavior, was a better marker of steroid-induced trouble than HbA1c, which averages out over months and can mask a short, intense disruption.

Not All Steroids Raise Glucose Equally

If your doctor has some flexibility in which corticosteroid to prescribe, the choice can affect how high your blood sugar goes. A hospital-based study comparing four commonly used steroids found meaningful differences in average blood glucose over a week. Prednisolone produced the lowest average glucose at about 167 mg/dL, while methylprednisolone was the highest at roughly 194 mg/dL. Dexamethasone came in at about 187 mg/dL, and hydrocortisone at around 171 mg/dL.⁵ The differences between the worst and best options were around 25 to 27 mg/dL on average, enough to push a borderline patient from acceptable into poorly controlled territory.

Dexamethasone also has a much longer duration of action than prednisone, which means its glucose-raising effect lasts well into the next day. That extended window can make dose adjustments of diabetes medications harder to time. When there is a clinical choice, prednisolone or hydrocortisone tend to be gentler on glucose levels, though the underlying condition being treated often dictates which steroid is appropriate.

What About Steroid Injections?

People with diabetes often assume that a local injection, say a cortisone shot in the knee or shoulder, will not affect blood sugar the way oral prednisone does. That assumption is wrong, though the effect is milder and shorter-lived. A study tracking blood glucose after musculoskeletal steroid injections in patients with diabetes found a significant glucose elevation on the first day after injection. By the second day, glucose had generally returned to baseline.⁶

The size of the spike depended heavily on how well-controlled the person’s diabetes was going in. Patients with an HbA1c above 7% saw significantly larger glucose increases than those with better control, and patients already on insulin saw bigger jumps than those who were not. The injection site and steroid dose did not make a significant difference. So if you are getting a joint injection, the most important factor is your baseline glucose control, not how much steroid goes in. A systematic review of steroid use in type 1 diabetes confirmed the same pattern for local injections in that population: the glucose excursions were delayed but prolonged, and careful monitoring was still necessary.⁷

Serious Acute Risks

For most people with diabetes, prednisone means temporarily higher blood sugar that can be managed with medication adjustments. But in a small number of cases, things escalate to dangerous territory. Diabetic ketoacidosis, the emergency where the body starts breaking down fat into toxic ketones, has been reported in patients with type 2 diabetes after starting prednisone. One documented case involved a middle-aged patient whose type 2 diabetes had been well controlled on metformin alone. After starting oral prednisone for a herniated disc, the patient developed full-blown DKA with no other identifiable trigger.⁸

DKA has also occurred in people without any prior diabetes diagnosis. A case review described an obese 73-year-old with no known diabetes who developed DKA after two months on high-dose steroids. The clinical picture matched a condition called ketosis-prone type 2 diabetes, suggesting that steroids can unmask a latent vulnerability in certain people.⁹ A separate case documented hyperosmolar hyperglycemic syndrome, another glucose emergency, in a 29-year-old man with no diabetes history who was given standard-dose prednisolone for a kidney condition.¹⁰

These are rare events, and they tend to occur at higher doses or longer courses. But they illustrate that the glucose disruption from prednisone is not just an inconvenience. For someone with existing diabetes, the risk floor is already elevated. Symptoms to watch for include nausea, vomiting, excessive thirst, confusion, and blood sugar readings above 300 mg/dL that do not respond to your usual correction dose.

When Prednisone Triggers New Diabetes

Steroid-induced diabetes is its own clinical entity. A study comparing patients who developed new-onset steroid-induced diabetes with those who had pre-existing type 2 diabetes found some interesting differences. The steroid-induced group had less family history of diabetes and weighed less than the type 2 group, despite being on steroids known to cause weight gain.¹¹ None of the patients with new-onset steroid-induced diabetes had retinopathy, a complication that takes years to develop, suggesting this was genuinely new disease rather than pre-existing diabetes that had gone undiagnosed. The new-onset group was more frequently treated with insulin.

A large population study across six immune-mediated inflammatory diseases found that the risk of developing type 2 diabetes rose with increasing glucocorticoid dose. Among patients with a normal BMI, higher daily doses carried a larger increase in diabetes risk compared to patients who were already overweight, where the risk was elevated at any dose.¹² This means even lean patients on moderate-to-high steroid doses should have their glucose checked periodically, especially if the course lasts more than a few weeks.

How Insulin Doses Typically Need to Change

For people with type 1 diabetes, glucocorticoid exposure consistently requires a substantial increase in insulin. A systematic review pooling data from 22 studies found that oral and intravenous steroid regimens often required insulin dose escalation of up to 70% above baseline.⁷ That is not a minor tweak. If you normally take 40 units of insulin per day, you might need close to 70 units while on prednisone. The review also noted that automated insulin delivery systems helped blunt the glucose spikes but still required user intervention, meaning you cannot just rely on a pump’s algorithm to handle the full load.

For people with type 2 diabetes, adjustments depend on your current regimen. If you are on oral medications alone, you may need temporary insulin added on top, particularly a dose timed to cover the afternoon and evening peak. If you already use insulin, your prescriber will often increase your intermediate-acting or long-acting dose, sometimes adding a specific afternoon bolus. The exact strategy varies, and this is emphatically not something to self-adjust without guidance. Clinical guidelines for managing steroid-induced hyperglycemia in hospitals acknowledge that evidence-based treatment targets and management protocols are still lacking, which is part of why the process relies so heavily on individualized monitoring.¹³

When the prednisone course ends, the insulin adjustments need to be reversed, and this is another dangerous window. Stopping or tapering the steroid while keeping a boosted insulin dose invites hypoglycemia. Many people focus on the high blood sugar going up but forget to plan for the descent.

The Doubled Infection Risk

Diabetes by itself increases the risk of infection. Prednisone suppresses the immune system. Together they create a compounding vulnerability. Guidelines from EULAR on corticosteroid use in rheumatoid arthritis specifically call out diabetes as a risk factor that should prompt clinicians to limit steroid use or individualize therapy carefully, given the infection-related dangers.¹⁴ This dual risk is often underappreciated. Higher blood sugar itself impairs white blood cell function, and prednisone’s immunosuppression makes it harder for the body to recognize and fight pathogens. The combination is particularly concerning for respiratory infections, urinary tract infections, and skin infections. If you develop signs of infection while on prednisone, such as a fever that does not resolve, painful urination, or a wound that worsens instead of healing, contact your healthcare provider promptly rather than waiting to see if it improves on its own.

Pregnancy and Prednisone in Diabetic or At-Risk Women

Prednisone is sometimes prescribed during pregnancy for autoimmune conditions, threatened miscarriage, or to help fetal lung development before a preterm delivery. For women who already have diabetes, the glucose consequences are significant. A study of women with pregestational diabetes who received antenatal corticosteroids found that only about 2% achieved adequate glycemic control during the steroid course.¹⁵ The methods of glycemic control used did not significantly affect neonatal outcomes, but neonates with complications were more likely to have been born to mothers who received less insulin, suggesting that under-treatment was a bigger problem than the steroid itself.

Even women without existing diabetes face risk. A prospective cohort study of women taking low-dose prednisone during pregnancy for recurrent spontaneous abortion found a significantly higher incidence of gestational diabetes in the prednisone group. A family history of diabetes combined with prednisone use further elevated the risk of glucose abnormalities during pregnancy.¹⁶ The researchers recommended routine glucose and C-peptide monitoring for any pregnant patient on prednisone, even at low doses. If you are pregnant or planning to become pregnant and your doctor suggests prednisone, asking about a glucose monitoring plan from the start is reasonable.

Steroid-Sparing Alternatives

For some conditions, the question is not just how to manage prednisone safely but whether it can be avoided altogether. The rise of biologic therapies over the past two decades has given doctors new tools to treat autoimmune and inflammatory diseases while reducing or eliminating steroid use. A scoping review of randomized controlled trials in lupus examined the steroid-sparing effects of biologic agents. Among the eight trials reviewed, four demonstrated a clear steroid-sparing effect, with drugs like belimumab and anifrolumab allowing patients to taper prednisone below 7.5 mg per day. In one trial, an intensified dosing regimen of anifrolumab achieved sustained prednisone tapering in over half of patients, compared to a third in the placebo arm.¹⁷

Biologics are not an option for every condition that currently calls for prednisone. Short courses for acute flares of asthma or COPD, for example, do not have a practical biologic substitute yet. And biologics carry their own side effects and costs. But if you have diabetes and are on long-term or recurrent steroid therapy for an autoimmune condition, asking your specialist whether a steroid-sparing biologic is appropriate for your situation is a conversation worth having. The goal is not to eliminate steroids from the toolkit entirely but to use them at the lowest effective dose for the shortest necessary time, a principle that carries extra weight when glucose control is already a daily challenge.

Practical Steps Before Starting a Course

If your doctor prescribes prednisone and you have diabetes, a few things are worth establishing before you fill the prescription. First, make sure the prescribing provider knows you have diabetes, especially if the prescription comes from someone other than your usual diabetes care team, such as a pulmonologist or rheumatologist. It sounds obvious, but in fragmented healthcare systems, this information can slip through the cracks.

Second, ask about the expected dose and duration. A three-day burst at 40 mg for an asthma flare will have different glucose consequences than six weeks at 20 mg for an autoimmune condition. Your diabetes medication adjustments should match the expected course. Third, plan your monitoring. If you normally check blood sugar once or twice a day, you will likely need to check more often, particularly in the afternoon and before bed, to catch the characteristic delayed spike. If you have access to a continuous glucose monitor, this is an ideal time to use it.

Fourth, ask your prescriber or pharmacist how the steroid will be tapered. Many prednisone courses end with a gradual dose reduction rather than a sudden stop, both to prevent adrenal insufficiency and to let your diabetes medications be stepped down in parallel. Knowing the taper schedule in advance means you can plan your insulin or medication adjustments proactively rather than reacting to lows after the steroid stops. Finally, know the warning signs that suggest you need immediate medical attention: blood sugar persistently above 300 mg/dL, nausea or vomiting with fruity-smelling breath, confusion, or extreme thirst with infrequent urination. These can signal the emergency complications discussed earlier, and they warrant a call to your provider or a trip to the emergency department rather than a wait-and-see approach.